Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
about
Vesicular monoamine transporter 2: role as a novel target for drug developmentNeurofunctional imaging of β-cell dynamicsImaging pancreatic islet cells by positron emission tomographyComputational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseThe vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.Preparation and Characterization of Tetrabenazine Enantiomers against Vesicular Monoamine Transporter 2.No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease.Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation.Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.Derivatization of (±) dihydrotetrabenazine for copper-64 labeling towards long-lived radiotracers for PET imaging of the vesicular monoamine transporter 2.In vitro and ex vivo characterization of (-)-TZ659 as a ligand for imaging the vesicular acetylcholine transporterPharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transportersIn vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusersA Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2Synthesis of (±)-Tetrabenazine by Visible Light Photoredox Catalysis11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.Visualizing pancreatic beta-cell mass with [11C]DTBZ.PET radioligands for the vesicular transporters for monoamines and acetylcholine.Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and ValbenazineIslet grafting and imaging in a bioengineered intramuscular space.In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation.Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates.Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.Valbenazine granted breakthrough drug status for treating tardive dyskinesia.In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering.Analysis of four dopaminergic tracers kinetics using two different tissue input function methods.Synthesis and biological evaluation of 10-(11) C-dihydrotetrabenazine as a vesicular monoamine transporter 2 radioligand.
P2860
Q24647764-D1EB4410-890E-4DDF-B1C6-A65BC6588564Q26829645-9B4F9214-E2B7-41CF-873C-7C70399E2090Q28075496-7407728C-E063-4B85-B2A6-F2271D987246Q28290902-3B2B28CA-C04A-435A-B91C-4CD1A2E199F3Q30498938-2595D670-0618-4D75-9D9B-C6C34D8EEB78Q33854736-569AE806-B984-4616-B4BA-02B5414D76C5Q34042123-EA10ADEA-DC62-4CCA-BF1B-07BE7F7DB5FDQ34168229-9D1EC954-AD95-4EDC-89BF-2BEB35710A6DQ34202539-66C0E132-5F7A-4CB5-985E-8E32AA46ECABQ34442240-846E0370-D91A-449E-8428-917CB06DBA5FQ34765909-62C1D4D8-2941-417C-9E7B-567C84DF60DAQ35124993-FBDE0A29-67B3-4DDF-B15F-90CEABD6F3D0Q35204649-A3AAD718-6217-416D-B3F0-969C60F45EB3Q35867486-99F43E38-6971-4251-BEAD-0BDCB92CCB48Q35891436-ECB044DE-9786-4286-87AE-F082708FFF9EQ36118252-FECCAD82-77B3-4190-9765-BC80930A4C95Q36128614-A65B4F53-F3BE-4FB9-8C86-16EB03047CAAQ36386171-8FA645FE-FD38-4921-9133-7DDBF05808CCQ36774879-496F9DDA-B714-4949-8608-4AC2D46C9CC5Q37094838-054E268F-124E-4459-9DB6-EC6050C3758AQ38166971-E38113A5-F3DF-4A63-BD0C-8FF9142B9FA2Q38641750-750D121E-F67D-4D60-A576-18F6DEA810AFQ42716769-8FF6A240-8FA1-4DA2-BD62-A7FC1F43CEBAQ43856181-C25B31EB-BDC1-4D74-B508-CA7403DC80C4Q46635617-4776639D-DB31-4E3C-9017-D7A5FE23508CQ46865314-8EB5210C-22A9-494F-907A-D94947C3D1F7Q46900351-67C574C0-2D82-4ACC-A99A-5DD8B6F9362CQ48088881-CA6C1CBD-41B3-4471-904D-B74969C1F902Q48300190-7CF25DFB-B37B-4FBE-872A-03871F81497FQ48401808-91066FE4-B165-4D69-B18A-B144364AF5EBQ52921276-D3725510-D485-486A-94BE-6E71CC9A8C37Q53080671-6D45BAAD-EB95-44F9-AEA5-39413D199CED
P2860
Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@ast
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@en
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@nl
type
label
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@ast
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@en
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@nl
prefLabel
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@ast
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@en
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@nl
P2093
P1476
Binding of alpha-dihydrotetrab ...... transporter is stereospecific.
@en
P2093
P304
P356
10.1016/0014-2999(95)00162-E
P407
P577
1995-05-01T00:00:00Z